SIRT3 Gene & Longevity - Key Research Links

Foundational & Classic Studies

• SIRT3 polymorphism and human longevity - The landmark study showing the VNTR in intron 5 of SIRT3 is enriched in long-lived Italian individuals: PubMed - Rose et al. (2003) SIRT3 and survival
• Sirt3, mitochondrial ROS, ageing, and carcinogenesis (Park SH et al., Int J Mol Sci, 2011) - Review connecting SIRT3 to ROS suppression and aging biology: PMID 22016654

Recent Reviews (2022-2025)

Experimental / Animal Studies

• SIRT3 deficiency decreases oxidative metabolism but INCREASES lifespan in male mice under caloric restriction (Dhillon RS et al., Aging Cell, 2022) - Surprising finding that challenges the simple "more SIRT3 = longer life" model: PMID 36199173
• SIRT3 overexpression restores aged hematopoietic stem cell regenerative capacity and mediates caloric restriction benefits - cited in a 2025 Frontiers epigenetic pharmacology review: Frontiers Pharmacology 2025

Key Mechanisms SIRT3 Controls in Aging

Useful Search Entry Points

• PubMed SIRT3 + longevity: Search link
• PubMed SIRT3 + mitochondria + lifespan (2021-2026): Search link
• GeneCards - SIRT3: genecards.org/cgi-bin/carddisp.pl?gene=SIRT3
• OMIM - SIRT3 entry: omim.org/entry/604481

SIRT3 Genetic Association Studies in Human Centenarians

The Landmark Studies (Bellizzi / Rose Group, Italy)

1. Bellizzi et al. (2005) - The Foundational Study

• Journal: Genomics, 85(2):258-263
• PMID: 15676284
• DOI: 10.1016/j.ygeno.2004.11.003
• What they found: Discovered a 72-bp VNTR repeat in SIRT3 intron 5. In a sample of 945 individuals aged 20-106, the allele that completely lacks enhancer activity was virtually absent in males older than 90 years. This is the first and most-cited direct human genetic evidence linking SIRT3 to longevity.
• Key caveat: The effect was sex-specific (males only), suggesting X-chromosome interactions or hormonal modulation.

2. Lescai et al. (2009) - The Large Replication Attempt

• Journal: European Journal of Human Genetics, 17(11):1515-9
• PMID: 19367319
• DOI: 10.1038/ejhg.2009.54
• What they found: Scanned the entire 11p15.5 locus (2.8 Mb, containing SIRT3, HRAS1, TH, INS, IGF2) with 239 SNPs across 1,321 centenarians and 1,140 controls from 4 European cohorts (the largest centenarian genetic study at the time). Results:
  • Could not replicate the original Bellizzi VNTR finding at conventional significance
  • One SNP showed a signal in meta-analysis: rs939915 in SIRT3
  • Six additional SNPs at the broader locus showed significance for common genotypes
• Significance: While largely negative, it established that SIRT3 longevity associations may be population-specific, sex-specific, or require larger samples.

TRELONG Prospective Study (2014) - The Prospective Confirmation

3. Albani et al. (2014)

• Journal: Age, 36:469-478
• DOI: 10.1007/s11357-013-9559-2
• What they found: In a systematically selected prospective cohort from Treviso, Italy, a gain-of-function SNP that enhances SIRT3 enzymatic activity was significantly associated with increased survival in elderly participants. This is the only prospective longitudinal study to confirm the SIRT3-longevity link in humans.
• Importance: Moves beyond cross-sectional centenarian comparisons to actual survival tracking - the strongest design for a longevity gene claim.

Key Context from Recent Reviews (2025)

4. Sešelja et al. (2025) - Current State of the Field

• Journal: Genes (MDPI), 16(12):1497
• Link: mdpi.com/2073-4425/16/12/1497
• Summary: Confirms SIRT3 as "the only sirtuin isoform directly linked to human longevity" (citing the VNTR data). Notes a separate SNP in SIRT3 reduces enzymatic activity and increases metabolic syndrome risk. Highlights the TRELONG study as the strongest human evidence.

5. You & Wang (2025) - Comprehensive Aging Review

• Journal: Int J Biol Sci
• PMID: 40860195
• Reaffirms: "SIRT3 is the only isoform directly linked to human longevity" via the 2005 VNTR study, and consolidates mechanism data.

Summary Table of Human Genetic Association Evidence

What Is Still Missing

1. No large-scale GWAS has specifically interrogated the SIRT3 locus in centenarians with modern array densities (post-2015).
2. The sex-specific effect (males only in Bellizzi 2005) has never been fully explained or replicated in a sex-stratified GWAS.
3. The VNTR itself is difficult to genotype on standard arrays, meaning most longevity GWAS studies would miss it entirely.
4. There are no studies from non-European populations testing SIRT3 genetic variants in centenarians (a major gap).

Functional Validation Studies on the SIRT3 VNTR Enhancer Mechanism

The Mechanistic Series (Bellizzi & Rose Group)

STEP 1 - Discovery of the G477T Marker (2003)

• Journal: Exp Gerontol, 38(10):1065-70
• PMID: 14580859
• DOI: 10.1016/S0531-5565(03)00209-2
• What it showed: First human study on SIRT3. Genotyped the G477T SNP in SIRT3 in elderly Italians. Found that in males, the TT genotype significantly increases survival (p=0.027) while GT decreases survival (p=0.039). Established the 11p15.5 locus (alongside HRAS1, IGF2, INS, TH) as a longevity candidate region.

STEP 2 - Functional Validation of the VNTR Enhancer (2005) - The Core Mechanism Paper

• Journal: Genomics, 85(2):258-263
• PMID: 15676284
• DOI: 10.1016/j.ygeno.2004.11.003
• Functional experiments performed:
  1. PCR-based VNTR discovery: Identified a 72-bp repeat core in SIRT3 intron 5 with alleles differing in repeat number AND presence/absence of putative regulatory binding sites
  2. Transient transfection / luciferase reporter assay: Cloned VNTR alleles upstream of a reporter gene in HeLa cells - demonstrated allele-specific enhancer activity (the active allele drives significantly higher reporter expression)
  3. Regulatory site analysis: The "no-enhancer" allele lacks specific transcription factor binding motifs present in the active allele
  4. Population genetics: In 945 individuals (age 20-106), the no-enhancer allele is virtually absent in males >90 years - directly linking enhancer loss to reduced survival
• Conclusion: Underexpression of SIRT3 due to loss of the intronic enhancer is detrimental to longevity in males.

STEP 3 - Bidirectional Promoter with PSMD13 (2007) - Extended Mechanism

• Journal: Genomics, 89(1):143-50
• PMID: 17059877
• DOI: 10.1016/j.ygeno.2006.09.004
• Functional experiments performed:
  1. Deletion mutant transfections in HeLa cells: Systematically deleted segments of the 788-bp SIRT3-PSMD13 intergenic region to map cis-regulatory elements driving each gene
  2. Bidirectional promoter activity: Showed that a single intergenic sequence drives transcription in both directions - toward SIRT3 and toward PSMD13 (a 26S proteasome subunit whose function also declines with aging)
  3. Linkage disequilibrium analysis in 710 subjects (age 18-108): Found high LD between the PSMD13 A21631G marker, SIRT3 G477T SNP, and the intron 5 VNTR - with significantly different haplotype pools between centenarians and younger controls
• Key implication: SIRT3 longevity variants are part of a co-regulated aging gene cluster - the VNTR enhancer may modulate both SIRT3 and PSMD13 simultaneously through shared regulatory architecture.

Independent Clinical Validation - VNTR in Disease (2023)

• Journal: Asian Pac J Cancer Prev, 24(3):859-865
• PMID: 36974538
• DOI: 10.31557/APJCP.2023.24.3.859
• PMC: PMC10334083
• Design: Case-control, 200 breast cancer cases vs 202 controls (Hyderabad, India)
• PCR genotyping results: The 0R allele (zero repeats = no enhancer) and 0R/0R genotype are significantly associated with breast cancer risk:
  • OR for 0R/0R genotype: 2.67 (95% CI: 1.54-4.65), p=0.000005
• Functional interpretation: Confirms Bellizzi's model - loss of the intronic enhancer → reduced SIRT3 expression → impaired mitochondrial ROS defense → increased cancer susceptibility. This is the most recent independent functional validation in an Indian population.

Mechanistic Map - What the Enhancer Controls

SIRT3 VNTR (intron 5)
        |
   Enhancer active allele          No-enhancer (0R) allele
        |                                  |
  ↑ SIRT3 transcription           ↓ SIRT3 transcription
        |                                  |
  ↑ SIRT3 protein (mitochondria)   ↓ SIRT3 protein
        |                                  |
  Deacetylates: MnSOD (SOD2)        ↑ Acetyl-MnSOD (inactive)
                IDH2                 ↑ ROS accumulation
                FOXO3                ↑ Mitochondrial dysfunction
                LCAD (fat oxidation) → Disease / reduced lifespan
        |
  ↓ ROS → ↑ Survival to oldest ages
  + Co-regulates PSMD13 (proteasome)
    via bidirectional promoter

Summary Table of Functional Validation Studies

Key Research Gap

PARP1 Gene & Longevity - Complete Research Link Guide

Core Biology - Why PARP1 Matters for Longevity

Research Links - Organized by Theme

I. Cross-Species Evidence (The Strongest Correlation)

• Journal: PNAS, 89(24):11759-11763
• DOI: 10.1073/pnas.89.24.11759
• PubMed: https://pubmed.ncbi.nlm.nih.gov/1465395/
• What it showed: In PBMCs of 13 mammalian species (rat → gorilla → human), maximum poly(ADP-ribosyl)ation capacity strongly and positively correlates with maximum species lifespan. Humans have ~5x higher PARP1 activity than rodents. This is the most-cited piece of evidence linking PARP1 to longevity and remains unreplicated in scope.

• Journal: Mech Ageing Dev, 131(5):366-369
• DOI: 10.1016/j.mad.2010.04.003
• Key finding: The cross-species difference in PARP1 activity is not due to different enzyme levels but due to intrinsically higher catalytic capacity of the human PARP1 protein compared to the mouse orthologue - a direct functional validation at the protein level.

II. Human Centenarian Studies

• Journal: J Mol Med, 76:346-354
• DOI: 10.1007/s001090050226
• PubMed: https://pubmed.ncbi.nlm.nih.gov/9587071/
• Finding: Lymphoblastoid cell lines from French centenarians (100+ years) show significantly higher PARP activity than cell lines from 20-70 year-olds - comparable to those of young adults. This is the direct human centenarian functional data.

• Journal: J Mol Med (Berl), 78(8):431-40
• PMID: 11097112
• DOI: 10.1007/s001090000132
• Design: 324 French centenarians vs 324 controls; 4 PARP1 coding SNPs tested (including V762A - the most studied variant)
• Critical finding: No enrichment of any PARP1 coding SNP in centenarians. The higher PARP1 activity in centenarians is NOT explained by coding-sequence variants.
• Implication: The longevity-linked higher PARP activity is likely due to epigenetic/regulatory differences, not coding mutations - exactly paralleling the SIRT3 VNTR enhancer story.

III. Reviews Synthesizing the Evidence

• Journal: Exp Gerontol, 39(11-12):1599-604
• PMID: 15582275
• DOI: 10.1016/j.exger.2004.07.010
• Summary: The definitive review from the group that established the cross-species correlation. Discusses PARP1 as both a DNA repair survival factor (low-moderate genotoxic stress) and a mechanism for retarding mutation accumulation. Covers their dominant-negative mouse model showing that PARP1 suppresses genomic instability and carcinogenesis.

• Journal: J Aging Res, 2012:321653
• PMC: PMC3459245
• DOI: 10.1155/2012/321653
• This is the essential comprehensive read. Explains:
  • The positive correlation data (cross-species, centenarians)
  • The paradox: ectopic human PARP1 in mice causes premature aging and inflammatory pathologies
  • The V762A hypomorphic SNP as a cancer risk factor
  • PARP1 hyperactivation → NAD+ depletion → mitochondrial failure → accelerated aging
  • Proposed "Goldilocks" model: optimal, not maximal PARP1 activity promotes longevity

• Journal: Mech Ageing Dev, 131(6):425-40
• PMID: 20561897
• DOI: 10.1016/j.mad.2010.05.005
• Experimental finding: Mice overexpressing human PARP-1 show impaired survival + premature aging phenotypes: adiposity, kyphosis, nephropathy, dermatitis, cardiomyopathy, pneumonitis, anemia, delayed DNA repair, and pro-inflammatory cytokine dysregulation. Directly proves that too much PARP1 is harmful despite higher activity correlating with longevity across species.

IV. PARP1/NAD+/Sirtuin Axis (Most Recent)

• Journal: Aging Cell, Jan 2026
• PMID: 41436848
• PMC: PMC12727671
• DOI: 10.1111/acel.70319
• Key message: PARP1 hyperactivation (hyperparylation) in DNA repair disorders depletes NAD+ and drives premature aging. NAD+ supplementation restores repair capacity and mitochondrial function. Directly translates the PARP1-longevity paradox into therapeutic strategy.

• A rare centenarian SIRT6 variant was found to enhance PARP1 activation at DNA breaks (via mono-ADP-ribosylation), improving DSB repair efficiency and correlating with exceptional longevity - described in the EMBO J (2022) centenarian SIRT6 paper.

Key Databases & Live Search Links

PARP1 vs SIRT3 - Comparison of Their Longevity Evidence

PARP1 Gene SNPs & Longevity - Complete Research Guide

All Known PARP1 SNPs Tested for Longevity

SNP 1: Exon 1 Polymorphic Repeats

• PubMed search: PARP1 longevity Italian
• First attempt to directly genotype PARP1 repeat variants in centenarians.

SNP 2: C402T, T1011C, G1215A, T2444C (V762A / rs1136410)

• Val→Ala substitution in the catalytic domain (exon 17)
• Reduces PARP1 enzymatic activity
• Strong LD with rs1805415 (see below)
• Established as a cancer risk factor in multiple studies (bladder, breast, lung, esophageal cancers) - meaning lower DNA repair capacity increases cancer susceptibility
• In the NAD pathway pharmacogenomics context: rs1136410 carriers respond differently to PARP inhibitor therapy (olaparib, niraparib)
• Reference: IJPS Journal 2026 - NAD Pathway Variants

SNP 3: rs3219142 (CHARGE Consortium GWAS)

• PubMed: CHARGE Consortium longevity GWAS
• This is the most statistically powered study, and PARP1 variants still did not reach genome-wide significance.

SNP 4: rs1805415 (in strong LD with V762A/rs1136410) - The Most Interesting Result

SNP 5: rs3219090 - Activity-Enhancing Variant

• Reference: BMC Cancer 2013 - PARP1 rs3219090 melanoma

Summary Table - All PARP1 SNPs Tested for Longevity

Why No PARP1 SNP Has Reached Significance for Longevity

1. Epigenetic regulation - Centenarian cells maintain PARP1 and PARP2 expression at youthful levels (Chevanne et al. 2007, PMID 17518695) while normal aging reduces expression by ~50%
2. Promoter/regulatory SNPs - Not yet systematically studied; the VNTR/enhancer story from SIRT3 suggests regulatory variants may be more important than coding ones
3. Post-translational regulation - SIRT6 activates PARP1 via mono-ADP-ribosylation; variation in this axis may matter more than PARP1 coding sequence itself
4. Small effect sizes - PARP1 SNP effects on longevity are much smaller than lifestyle factors (BMI, smoking)

Key Resources for Further Research

PARP1 SNPs & Aging - Comprehensive Research Guide

The Master SNP: V762A / rs1136410 (T2444C, Exon 17)

Meta-Analyses on V762A and Aging-Related Disease

Meta-Analysis 1 - Qin et al. (2014)

Meta-Analysis 2 - Hua et al. (2014)

Meta-Analysis 3 - Xin et al. (2021) - Most Recent

PARP1 SNPs Across Specific Aging Phenotypes

1. Cancer (Age-Related Somatic Disease)

2. Inflammaging - The rs1805415 / IL-6 Connection

• rs1805415 (strong LD with V762A) raises baseline IL-6 by 15-20% per minor allele (p < 10⁻⁴)
• Higher IL-6 → chronic low-grade inflammation ("inflammaging") → accelerated aging phenotypes
• This is the only PARP1 SNP with a replicated biological effect on an aging biomarker

3. Premature Aging Syndromes

4. Epigenetic Aging (Expression, Not Sequence)

• Normal aging (69-75y): PARP1 and PARP2 expression reduced by ~50% vs young adults
• Centenarians (100-107y): PARP1/PARP2 expression maintained at youthful levels
• Centenarians show faster, more complete DNA repair after H₂O₂ damage
• The maintenance is due to epigenetic control (chromatin/methylation), NOT coding SNPs
• Both modified PARP1 protein AND poly-ADP-ribosylated chromatin proteins are better preserved in centenarians

5. PARP1 SNPs in the NAD+ Aging Network

DNA damage
    ↓
PARP1 activated → consumes NAD+
    ↓
[V762A Ala allele = reduced activity]
    ↓
Less NAD+ consumed per break          More mutations accumulate
       ↓                                        ↓
NAD+ "preserved"                     Genomic instability
       ↓                                        ↓
More available for SIRTs          Accelerated aging (carcinogenesis)
(SIRT1, SIRT3)

Complete SNP Summary Table

Key Live Search Links

MAOA Gene SNPs & Cognitive Function - Complete Research Guide

The MAOA Gene - Quick Biology

The Master Variant: MAOA-uVNTR (Upstream VNTR)

Key MAOA SNPs

Research by Cognitive Domain

1. Intelligence (IQ)

• MAOA-uVNTR independently predicted Full-Scale IQ, Performance IQ, and Verbal IQ (p=0.009, 0.019, 0.038)
• The COMT ValVal + MAOA-3R genotype combination predicted the highest IQ (average FSIQ ~107)
• COMT ValVal + MAOA-4R predicted lower IQ (~98)
• Key implication: MAOA-L (3R) combined with lower COMT activity may optimize prefrontal dopamine for cognitive performance
• Reference: PubMed - COMT x MAOA IQ in ADHD

2. Working Memory & Executive Function

• Cerasa et al. (2008): MAOA-H females showed better working memory under high load in fMRI
• Multiple other groups (Barnett 2011, Dumontheil 2014, Soderqvist 2014): no working memory effect

3. Prefrontal Cortex Regulation & Executive Control

• In an approach-avoidance task with emotional stimuli, MAOA-L carriers show greater regulatory activity in right DLPFC during conflict conditions (fNIRS study)
• Interpreted as a compensatory mechanism - MAOA-L individuals must recruit more PFC resources to override emotional impulses
• Implication: MAOA-L may reduce cognitive efficiency in emotionally charged situations despite similar baseline performance

• Multiple fMRI studies show altered vmPFC and ACC activity in MAOA-L carriers
• These regions are central to decision-making, risk assessment, and impulse control - all higher-order cognitive functions

4. Attention & Pre-Attentive Processing

• Combined 5-HTTLPR + MAOA-uVNTR genotype affects pre-attentive EEG responses (mismatch negativity, MMN) to threatening voices
• Demonstrates that MAOA variants modulate the earliest stages of attentional processing before conscious awareness
• Reference: Nature Communications Biology (2022)

• This specific SNP variant is associated with low visuospatial working memory performance - a distinct cognitive subdomain
• Also linked to maladaptive behavior, suggesting a cognitive-behavioral phenotype cluster

5. MAOA in Neurodegeneration & Aging Cognition

• MAOA (not MAOB) activity is implicated in neurodegeneration - elevated in AD brain regions
• Syed et al. (2023) PMID 37445985 compared MAOA levels with Aβ plaques, tau, and TSPO in postmortem AD brain - showing MAOA co-localizes with AD pathology
• MAO-B inhibitors (selegiline, rasagiline) protect neurons through anti-apoptotic mechanisms, not just MAO inhibition per se
• MAO-A inhibitors (moclobemide) improve cognitive and emotional function in depression-associated cognitive decline

• MAOA expression is regulated by parkin, SIRT1, FOXO, presenilin-1, and microRNA - directly linking MAOA to the aging and longevity gene network (connecting it to the SIRT3 story)
• Low MAOA activity → elevated serotonin + NE → disrupted neurotransmitter system development affecting lifelong cognitive trajectory

6. MAOA-uVNTR and Cognitive Phenotypes - Brain Oscillatory Data

• 4.5R (MAOA-H) carriers: greater gamma oscillation reactivity and greater heart rate variability
• 3.5R (MAOA-L) carriers: blunted gamma response
• Gamma oscillations are directly linked to working memory, attention binding, and conscious perception
• Reference: Scientific Reports 2019

Cognitive Domain Summary Table

Biological Mechanism Map

MAOA-uVNTR Allele
      |
 Low (2R/3R)          High (3.5R/4R/5R)
      ↓                       ↓
↑ 5-HT, DA, NE       Normal 5-HT, DA, NE
      ↓                       ↓
Over-stimulation       Optimal monoamine
of limbic circuits        clearance
      ↓                       ↓
↑ Amygdala reactivity    Efficient PFC
↑ Cortico-limbic          function
  hyperconnectivity         ↓
      ↓                Better IQ (some
Compensatory ↑ DLPFC    studies), calmer
(more cognitive effort      working memory
  per task)

Key Research Links & Databases

Critical Caveats

1. Sex matters enormously - MAOA is X-linked; males are hemizygous so effects are more penetrant. Most studies are in males for behavioral traits; the Yu 2005 cognitive study was females-only.
2. Gene-environment interaction - The cognitive and behavioral effects of MAOA-L are consistently amplified by early adversity (childhood abuse, stress). The genotype alone has weak effects; G×E effects are much stronger.
3. Ethnic differences - 3R is the dominant allele in Asian populations (~60%) whereas 4R dominates in Europeans (~65%). Population-specific cognitive studies must account for this.
4. The "warrior gene" framing is oversimplified - MAOA-L is associated with both risks (impulsivity, aggression under stress) and potential cognitive advantages (creativity, emotional intensity) in safe environments.
5. Most working memory findings are non-significant - The clearest cognitive effects are in emotionally-loaded executive control, not pure working memory span.